Alvesco Aerosol, Metered
NDC Package 70515-712-01
Package Information
Alvesco (ciclesonide) aerosols is ciclesonide is used to prevent and reduce the symptoms (wheezing and shortness of breath) caused by asthma. This formulation utilizes a aerosol, metered delivery system. Marketed by Covis Pharma Us, Inc, this product is identified by NDC 70515-712 and is authorized under FDA application NDA021658.
Identification & Billing
- RxCUI: 799034 - ciclesonide 160 MCG/INHAL Metered Dose Inhaler, 60 Actuations
- RxCUI: 799034 - 60 ACTUAT ciclesonide 0.16 MG/ACTUAT Metered Dose Inhaler
- RxCUI: 799034 - ciclesonide 160 MCG/ACTUAT Metered Dose Inhaler, 60 ACTUAT
- RxCUI: 799037 - Alvesco 160 MCG/INHAL Metered Dose Inhaler, 60 Actuations
- RxCUI: 799037 - 60 ACTUAT ciclesonide 0.16 MG/ACTUAT Metered Dose Inhaler [Alvesco]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70515 - Covis Pharma Us, Inc
- 70515-712 - Alvesco
- 70515-712-01 - 1 INHALER in 1 CARTON / 60 AEROSOL, METERED in 1 INHALER
- 70515-712 - Alvesco
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70515-712). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70515-712-01 identifies a specific commercial package of 1 inhaler in 1 carton / 60 aerosol, metered in 1 inhaler of Alvesco, a human prescription drug labeled by Covis Pharma Us, Inc. This aerosol, metered is formulated for respiratory (inhalation) use and contains ciclesonide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Covis Pharma Us, Inc on March 26, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Ciclesonide is used to prevent and reduce the symptoms (wheezing and shortness of breath) caused by asthma. Controlling asthma symptoms may decrease time lost from work or school. This medication belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. This medication must be taken regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed. Keep track of how often you need to use your quick-relief inhaler, and tell your doctor. If your quick-relief inhaler does not seem to work as well, if you need to use more than usual of your quick-relief inhaler for 2 or more days in a row, or if you need to use more than one full canister of your quick-relief inhaler over a 2-month period, seek immediate medical attention.
How is this Covis Pharma Us, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70515071201. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
